Lv3
336 积分 2023-09-18 加入
Benralizumab as an Adjuvant Therapy for Recurrent Laryngeal Papillomatosis
22天前
已完结
Comparative Efficacy of Biologic Agents for Severe Chronic Rhinosinusitis with Nasal Polyps: A Systematic Review and Network Meta-analysis
29天前
已完结
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype
4个月前
已完结
Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial
4个月前
已完结
Type 2 inflammation biomarkers and their association with response to dupilumab in COPD (BOREAS): an analysis of a randomised, placebo-controlled, phase 3 trial
5个月前
已完结
Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial
6个月前
已完结
Mepolizumab Prevents COPD Exacerbations in Trial
6个月前
已完结
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype
6个月前
已完结
Spatial adaptation of eosinophils and their emerging roles in homeostasis, infection and disease
6个月前
已完结
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial
7个月前
已完结
皖公网安备34019202002308
